Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P08397: Variant p.Arg149Gln

Porphobilinogen deaminase
Gene: HMBS
Feedback?
Variant information Variant position: help 149 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Arginine (R) to Glutamine (Q) at position 149 (R149Q, p.Arg149Gln). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (Q) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In AIP; severely decreased, if any, hydroxymethylbilane synthase activity. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 149 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 361 The length of the canonical sequence.
Location on the sequence: help FVGKTLETLPEKSVVGTSSL R RAAQLQRKFPHLEFRSIRGN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         FVGKT--LETLPEKSVVGTSSLRRAAQLQRKFPHLEFRSIRGN

Mouse                         FIGKT--LETLPEKSAVGTSSLRRVAQLQRKFPHLEFKSIR

Rat                           FIGKT--LETLPEKSAVGTSSLRRVAQLQRKFPHLEFKSIR

Bovine                        FVGKT--LETLPEKSVVGTSSLRRAAQLQRKFPHLEFKSIR

Slime mold                    KHGKNCKLSELPQGAMIGSSSLRRVAQLKKAYPHLQFKDIR

Baker's yeast                 SAYKS--LDDLPDGGIVGTSSVRRSAQLKRKYPHLKFESVR

Fission yeast                 SHYKT--VADLPPGSVVGTSSIRRRALLARNFPHLRFVDIR
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 361 Porphobilinogen deaminase
Modified residue 147 – 147 Phosphoserine
Helix 148 – 157



Literature citations
Molecular heterogeneity of acute intermittent porphyria: identification of four additional mutations resulting in the CRIM-negative subtype of the disease.
Delfau M.H.; Picat C.; de Rooij F.W.M.; Voortman G.; Deybach J.-C.; Nordmann Y.; Grandchamp B.;
Am. J. Hum. Genet. 49:421-428(1991)
Cited for: VARIANTS AIP GLN-149 AND ARG-245; Human porphobilinogen deaminase mutations in the investigation of the mechanism of dipyrromethane cofactor assembly and tetrapyrrole formation.
Shoolingin-Jordan P.M.; Al-Dbass A.; McNeill L.A.; Sarwar M.; Butler D.;
Biochem. Soc. Trans. 31:731-735(2003)
Cited for: CHARACTERIZATION OF VARIANTS AIP GLY-99; GLN-149; GLN-167 AND GLN-173; From a dominant to an oligogenic model of inheritance with environmental modifiers in acute intermittent porphyria.
Lenglet H.; Schmitt C.; Grange T.; Manceau H.; Karboul N.; Bouchet-Crivat F.; Robreau A.M.; Nicolas G.; Lamoril J.; Simonin S.; Mirmiran A.; Karim Z.; Casalino E.; Deybach J.C.; Puy H.; Peoc'h K.; Gouya L.;
Hum. Mol. Genet. 27:1164-1173(2018)
Cited for: VARIANTS AIP PHE-30 AND GLU-235; CHARACTERIZATION OF VARIANTS AIP SER-24; CYS-26; HIS-26; ASN-28; PHE-30; MET-35; PHE-96; ARG-111; TRP-116; ASP-124; GLN-149; LEU-149; HIS-217; GLU-235; ARG-247; ALA-250; GLN-250; VAL-250; TYR-256 AND MET-267;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.